Other Abnormal Uterine and Vaginal Bleeding
Conditions
Keywords
permenant occlusion, uterine bleeding, uterine arteries
Brief summary
Prospective observational interventional study , The study done in two phases: 1. Phase one from October 2011to May 2012 pilot study including twenty nine (29) premenopausal patients followed up for six months 2. Phase two from October 2012 till May 2014. Including Eighty nine (89) premenopausal patients all of them needing to preserve their uteri.
Detailed description
Abstract Objectives: To assess the effectiveness of permanent bilateral occlusion of uterine arteries in treatment of abnormal uterine bleeding. Design: prospective observational study Setting: Done in Mansoura university hospital, department of Obstetrics and gynecology. Patients and Methods: The study done in two phases: 1. Phase one from October 2011to May 2012 pilot study including twenty nine (29) premenopausal patients followed up for six months 2. Phase two from October 2012 till May 2014. Including Eighty nine (89) premenopausal patients all of them needing to preserve their uteri. Results: Results are hopeful and courageous in phase one as regards patients satisfaction, Quality of life and improvements of bleeding. Results of phase two will be implemented, analyzed and presented in tables. All data will be statistically analyzed and the results will be presented after completion of eighteen (18) months follow up to rule out any bias and/ or errors in the results. Conclusion: permanent bilateral uterine arteries occlusion may be a good alternative to radical surgery in abnormal uterine bleeding.
Interventions
PROCEDUREbilateral permanent occlusion of uterine arteries
bilateral permanent Occlusion of uterine arteries through abdominal route
Sponsors
Mansoura Integrated Fertility Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
34 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* premenopausal with abnormal uterine bleeding and completed their families having normal endometrium (biopsy in preceding 6 months ) and may have uterine intramural myomas not exceeding 150 ml in volume and away from uterine cavity by at least 1cm and /or adenomyosis
Exclusion criteria
* patients wishing future fertility * endometrial sampling not done or more than 6 months or myoma encroaching or distorting cavity or larger than 150 ml in volume
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| uterine bleeding | October 2011 till January 2016 |
Secondary
| Measure | Time frame |
|---|---|
| patient satisfaction | october 2011 - may 2015 |
| quality of life | october 2011 - may 2015 |
Countries
Egypt
Outcome results
None listed